Christoph Lengauer, Curie.Bio | Biotech Founders, Venture Capital | E57
We admire the mountains of Austria with the co-founder of Curie.Bio, a founder-friendly fund that...
How Europe could have more Biotech Champions like Argenx
For decades, the narrative of European biotech has been one of “innovation flight”: brilliant science...
Why Antimicrobial Resistance Is Bigger Than Cancer
We’ve been hearing about the Antimicrobial Resistance (AMR) crisis for over a decade. Yet, according...
Sander Slootweg, Forbion 🇳🇱 | European Biotech Investment, Venture Capital | E56
Forbion celebrates its 20th anniversary this year, with a whopping €5 billion raised so far....
![Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]](https://flot.bio/wp-content/uploads/2026/04/Website-Thumbnail-IMMUNOTHEP-1080x648.avif)
Solving Antimicrobial Resistance, Vaccines, Antibiotics | Immunethep 🇵🇹 | E55 [Sponsored]
Antibiotic-resistant superbugs could become a greater threat than cancer. Bruno and Pedro at the startup...
Biopharma family succession: Bial CEO António Portela’s strategy
In the high-stakes world of pharmaceutical innovation, few stories are as compelling as those of...
António Portela, Bial 🇵🇹 | Parkinson’s, Family-Owned Biotech | E54
We dive into Bial’s meteoric journey from a small pharmacy in Porto to Portugal’s biggest...
How AI, AlphaFold and Digital Twins are Transforming Biosolutions
Artificial intelligence is no longer a buzzword in biotech, it’s becoming core infrastructure. From protein...
Camurus CEO Fredrik Tiberg on Long-Acting Opioid Treatment
Turning Generics Into Game-Changing Therapies: Fredrik Tiberg of Camurus Explains the Power of Long-Acting Medicines...
Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53
Novonesis arose from a 2023 merger of Novozymes and Chr Hansen, and is a highly...
